CHLORHEXIDINE GLUCONATE

Chlorhexidine Gluconate Adverse Events Reported to the FDA Over Time

How are Chlorhexidine Gluconate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Chlorhexidine Gluconate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Chlorhexidine Gluconate is flagged as the suspect drug causing the adverse event.

Most Common Chlorhexidine Gluconate Adverse Events Reported to the FDA

What are the most common Chlorhexidine Gluconate adverse events reported to the FDA?

Anaphylactic Reaction	63 (4.05%)
Erythema	27 (1.74%)
Urticaria	27 (1.74%)
Burkholderia Cepacia Infection	26 (1.67%)
Hypotension	26 (1.67%)
Eye Inflammation	23 (1.48%)
Cardiac Failure Congestive	20 (1.29%)
Chronic Obstructive Pulmonary Disea...	19 (1.22%)
Anaphylactic Shock	17 (1.09%)
Cleft Lip And Palate	17 (1.09%)
Pruritus	17 (1.09%)
	Show More
Rash	17 (1.09%)
Dyspnoea	16 (1.03%)
Tachycardia	15 (.96%)
Blister	14 (.9%)
Dizziness	14 (.9%)
Hypersensitivity	14 (.9%)
Medication Error	14 (.9%)
Burning Sensation	13 (.84%)
Maternal Condition Affecting Foetus	12 (.77%)
Accidental Exposure	11 (.71%)
Ageusia	11 (.71%)
Caustic Injury	11 (.71%)
Dysgeusia	11 (.71%)
Swelling Face	11 (.71%)
Teratogenicity	11 (.71%)
Vomiting	11 (.71%)
Circulatory Collapse	10 (.64%)
Cystitis	10 (.64%)
Incorrect Route Of Drug Administrat...	10 (.64%)
Bacteraemia	9 (.58%)
Drug Hypersensitivity	9 (.58%)
Oxygen Saturation Decreased	9 (.58%)
Product Quality Issue	9 (.58%)
Rash Erythematous	9 (.58%)
Application Site Erythema	8 (.51%)
Application Site Reaction	8 (.51%)
Catheter Related Infection	8 (.51%)
Feeling Abnormal	8 (.51%)
Infection	8 (.51%)
Maternal Drugs Affecting Foetus	8 (.51%)
Pain	8 (.51%)
Pyrexia	8 (.51%)
Rash Pruritic	8 (.51%)
Skin Exfoliation	8 (.51%)
Skin Irritation	8 (.51%)
Swollen Tongue	8 (.51%)
Transmission Of An Infectious Agent...	8 (.51%)
Vulvovaginal Burning Sensation	8 (.51%)
Blood Pressure Decreased	7 (.45%)
Drug Exposure During Pregnancy	7 (.45%)
Excoriation	7 (.45%)
Flushing	7 (.45%)
Lip Swelling	7 (.45%)
Respiratory Failure	7 (.45%)
Skin Disorder	7 (.45%)
Skin Reaction	7 (.45%)
Tryptase Increased	7 (.45%)
Blood Disorder	6 (.39%)
Cleft Lip	6 (.39%)
Cleft Palate	6 (.39%)
Congenital Anomaly	6 (.39%)
Culture Positive	6 (.39%)
Emotional Disorder	6 (.39%)
Malaise	6 (.39%)
Nausea	6 (.39%)
Oral Discomfort	6 (.39%)
Sputum Culture Positive	6 (.39%)
Wrong Drug Administered	6 (.39%)
Abortion Induced	5 (.32%)
Blood Culture Positive	5 (.32%)
Cardiac Arrest	5 (.32%)
Convulsion	5 (.32%)
Diarrhoea	5 (.32%)
Eustachian Tube Dysfunction	5 (.32%)
Glossodynia	5 (.32%)
Hydrocele	5 (.32%)
Loss Of Consciousness	5 (.32%)
Oedema	5 (.32%)
Oedema Peripheral	5 (.32%)
Off Label Use	5 (.32%)
Otitis Media Chronic	5 (.32%)
Post Procedural Complication	5 (.32%)
Renal Failure	5 (.32%)
Sepsis	5 (.32%)
Throat Tightness	5 (.32%)
Abortion	4 (.26%)
Bronchospasm	4 (.26%)
Chills	4 (.26%)
Condition Aggravated	4 (.26%)
Cough	4 (.26%)
Cytolytic Hepatitis	4 (.26%)
Dermatitis Exfoliative	4 (.26%)
Eye Irritation	4 (.26%)
Eye Pain	4 (.26%)
Haemorrhage	4 (.26%)
Klebsiella Infection	4 (.26%)
Labile Blood Pressure	4 (.26%)
Necrosis	4 (.26%)
Oedema Mouth	4 (.26%)
Oral Disorder	4 (.26%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Chlorhexidine Gluconate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Chlorhexidine Gluconate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Chlorhexidine Gluconate

What are the most common Chlorhexidine Gluconate adverse events reported to the FDA?

Epidermal And Dermal Conditions	176 (11.32%)
Allergic Conditions	108 (6.95%)
Infections - Pathogen Unspecified	85 (5.47%)
Neurological	67 (4.31%)
Medication Errors	56 (3.6%)
Respiratory	45 (2.89%)
Decreased And Nonspecific Blood Pre...	42 (2.7%)
Bacterial Infectious	41 (2.64%)
Oral Soft Tissue Conditions	39 (2.51%)
Administration Site Reactions	38 (2.44%)
Ocular Infections, Irritations And ...	37 (2.38%)
	Show More
Chemical Injury And Poisoning	36 (2.32%)
Bronchial Disorders	30 (1.93%)
Gastrointestinal Signs	30 (1.93%)
Angiedema And Urticaria	28 (1.8%)
Cardiac Arrhythmias	27 (1.74%)
Microbiology And Serology	26 (1.67%)
Heart Failures	25 (1.61%)
Gastrointestinal Tract Disorders Co...	23 (1.48%)
Injuries	23 (1.48%)
Tongue Conditions	21 (1.35%)
Product Quality Issues	18 (1.16%)
Congenital And Hereditary	17 (1.09%)
Cardiac And Vascular Investigations	16 (1.03%)
Immunology And Allergy	14 (.9%)
Eye	13 (.84%)
Hematology Investigations	13 (.84%)
Procedural And Device Related Injur...	13 (.84%)
Dental And Gingival Conditions	12 (.77%)
Fetal Complications	12 (.77%)
Renal Disorders	11 (.71%)
Upper Respiratory Tract Disorders	11 (.71%)
Ancillary Infectious Topics	10 (.64%)
Hepatic And Hepatobiliary	10 (.64%)
Metabolic, Nutritional And Blood Ga...	10 (.64%)
Mood Disorders	9 (.58%)
Therapeutic Procedures And Supporti...	9 (.58%)
Vascular	9 (.58%)
Vulvovaginal Disorders	9 (.58%)
Anterior Eye Structural Change, Dep...	8 (.51%)
Body Temperature Conditions	8 (.51%)
Therapeutic And Nontherapeutic Effe...	8 (.51%)
Vision	8 (.51%)
Gastrointestinal Motility And Defec...	7 (.45%)
Injuries By Physical Agents	7 (.45%)
Hematological	6 (.39%)
Lifestyle Issues	6 (.39%)
Muscle	6 (.39%)
Musculoskeletal And Connective Tiss...	6 (.39%)
Salivary Gland Conditions	6 (.39%)
Seizures	6 (.39%)
Tissue	6 (.39%)
Environmental Issues	5 (.32%)
Fatal Outcomes	5 (.32%)
Hepatobiliary	5 (.32%)
Joint	5 (.32%)
Middle Ear Disorders	5 (.32%)
Musculoskeletal And Connective Tiss...	5 (.32%)
Obstetric And Gynecological Therape...	5 (.32%)
Physical Examination Topics	5 (.32%)
Reproductive Tract And Breast Disor...	5 (.32%)
Vascular Hemorrhagic	5 (.32%)
Abortions And Stillbirth	4 (.26%)
Eye Therapeutic Procedures	4 (.26%)
Fungal Infectious	4 (.26%)
Renal And Urinary Tract Neoplasms M...	4 (.26%)
Viral Infectious	4 (.26%)
Water, Electrolyte And Mineral	4 (.26%)
Anxiety Disorders	3 (.19%)
Appetite And General Nutritional	3 (.19%)
Bone Disorders	3 (.19%)
Electrolyte And Fluid Balance Condi...	3 (.19%)
Glucose Metabolism Disorders	3 (.19%)
Headaches	3 (.19%)
Hearing	3 (.19%)
Immune	3 (.19%)
Lower Respiratory Tract Disorders	3 (.19%)
Mental Impairment	3 (.19%)
Renal And Urinary Tract Investigati...	3 (.19%)
Sleep Disorders	3 (.19%)
Vascular Hypertensive	3 (.19%)
Arteriosclerosis, Stenosis, Vascula...	2 (.13%)
Cardiac Disorder Signs	2 (.13%)
Connective Tissue Disorders	2 (.13%)
Gastrointestinal Inflammatory Condi...	2 (.13%)
Gastrointestinal Neoplasms Malignan...	2 (.13%)
Glaucoma And Ocular Hypertension	2 (.13%)
Movement Disorders	2 (.13%)
Pregnancy, Labour, Delivery And Pos...	2 (.13%)
Protein And Chemistry Analyses	2 (.13%)
Psychiatric	2 (.13%)
Respiratory And Pulmonary Investiga...	2 (.13%)
Skin Vascular Abnormalities	2 (.13%)
Aneurysms And Artery Dissections	1 (.06%)
Aural	1 (.06%)
Cardiac Valve	1 (.06%)
Central Nervous System Vascular	1 (.06%)
Cranial Nerve Disorders	1 (.06%)
Deliria	1 (.06%)
Depressed Mood Disorders	1 (.06%)
Economic And Housing Issues	1 (.06%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Chlorhexidine Gluconate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Chlorhexidine Gluconate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.